Grace Therapeutics, Inc. (GRCE)

Net Income

-$15.79M

Quarterly · Period ending: · USD

GRCE logo

GRCE Net Income

Latest reported-$15.79M
GRCE Quarterly Net Income (-$188.82K → -$15.79M)
High-resolution chart · PNG

GRCE net income history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Grace Therapeutics, Inc. Net Income — Quarterly (USD)
Period endingNet Income (USD)
-15,790,000
-1,178,000
-3,176,480
-1,308,256
-3,362,000
905,733
-5,975,263
-3,432,000
-3,579,087
-4,296,293
-3,169,253
-4,432,394
-5,329,522
-39,341,088
-5,225,427
-4,929,000
-5,824,974
-4,877,943
-4,815,000
1,243,008
-4,769,073
-8,910,266
-5,249,960
-10,881,539
-8,582,768
24,348,430
-12,123,000
-21,158,000
-8,846,000
-13,099,701
-3,384,653
-17,591,969
-5,642,487
-6,024,131
-4,834,194
-3,633,124
-2,136,000
-1,784,092
-1,779,125
-2,418,229
-1,372,499
-1,638,827
-936,878
-777,078
-1,895,180
2,629,276
-3,413,996
1,250,065
-1,902,851
-3,632,068
-3,071,716
-1,906,613
-1,759,839
-1,621,896
-1,764,730
-1,529,364
-1,740,746
-2,137,363
-1,761,052
-1,047,553
-1,007,922
-605,807
-666,250
-513,978
-400,071
-377,760
-429,774
-276,979
-188,817
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.